Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
about
Pathogenicity of Moraxella osloensis, a bacterium associated with the nematode Phasmarhabditis hermaphrodita, to the slug Deroceras reticulatumCharacterization of a Moraxella species that causes epistaxis in macaquesCurrent progress with Moraxella catarrhalis antigens as vaccine candidatesComprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance modelLong-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalisIdentification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutantEnhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.Moraxella catarrhalis: from emerging to established pathogen.Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants.Inactivation of the Moraxella catarrhalis superoxide dismutase SodA induces constitutive expression of iron-repressible outer membrane proteinsSpecific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.Influence of Moraxella sp. colonization on the kidney proteome of farmed gilthead sea breams (Sparus aurata, L.).Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature.Identification of a novel two-partner secretion locus in Moraxella catarrhalis.Antimicrobial resistance in respiratory tract pathogens.Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infectionVaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.Community-Acquired Moraxella catarrhalis Bacteremic Pneumonia: Two Case Reports and Review of the LiteratureHigh prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional studyUse of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation.Molecular aspects of Moraxella catarrhalis pathogenesis.Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level.Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes.Endotoxin activity of Moraxella osloensis against the grey garden slug, Deroceras reticulatum.Comparison of two silver staining techniques for detecting lipopolysaccharides in polyacrylamide gelsA Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance.Comparison of restriction enzymes for pulsed-field gel electrophoresis typing of Moraxella catarrhalis
P2860
Q24549768-AE1714E3-5EBC-4252-A478-94522F66F682Q28289108-3CB9E9CE-D213-4719-9177-3BBB00051CCAQ28304447-BC54AC58-BFB8-4425-BA25-458751A53BE9Q28382833-F83557D6-CC03-4878-A5B7-ECD7146175CBQ28728017-836FAB1B-1B9A-481F-BB7E-344F06266EE5Q31015760-F44CC3FA-2B50-401E-9E29-5970A57FE261Q33597864-75DCBF6A-30F1-41EB-9291-3536B289FC60Q33673087-013C4AAA-1F60-43E2-A274-1FF8ABBAF492Q33753424-5AD8503B-6AE8-4B7D-A51E-2272746B4C04Q33755304-6B25842C-F3A4-43FC-812C-547A310ACBF0Q33761483-AC4F56D9-5F28-4096-8645-4C6D29EC6CD5Q33768943-97735C9E-114A-41B3-A1E6-008B168D7A6CQ33906182-2FE48F7C-818D-4764-AA79-5F0BE40BACD8Q34004983-64EF9729-E2EA-425D-B221-CA28043A070DQ34121049-964FCBFA-6F63-4C71-9AC5-C830F709C699Q34183386-140FF8CC-B489-4B84-9172-8446179D4D5DQ34243759-3B18753F-81CB-4F11-A32F-27FD0A0522A6Q34453823-3F5BC450-CF03-45EA-AAE9-36C6AE4CF952Q34778118-A9042F56-9D88-4859-81D6-D24C8D4D04E0Q34803770-92CC61E5-AB00-47D3-86FD-EAD60D0487C0Q35913464-0800311B-D835-4B59-9B0F-06DB8433D0D6Q35917507-75600D0F-6F49-436F-A3D8-AC3FD996AEE9Q35919024-5CCA8D57-9698-481A-A5BA-18453A85960BQ36098286-D55624E0-6C36-4A0D-9665-39E56D3CAAC4Q36325208-10BA84AF-D823-4089-BA73-29672FBBA6A2Q36350568-3572A005-A65E-4380-9D2D-C1FFC2F78AB8Q36644022-8E6C073B-C636-46B6-8C6A-D33328F7D368Q36754258-1F59EFC3-D964-4192-8248-EA3A0FE4EB07Q36976255-D06C5899-9067-4AAD-A0B3-887134C8968EQ37355837-39C21375-8A8E-462A-B408-3399B6F884EAQ37582908-AABD717B-BD8E-418B-8255-52F5A87D804EQ37590025-CB0C25AB-B2ED-44A5-9CF8-D7F7DECACDC7Q39502700-57077D86-36B6-44E7-AF90-9127B9144469Q39509622-FB47F88A-D6AB-4D61-B3C6-EDD5132BD580Q39572235-153EF183-C944-489D-A381-7229C39BC1B6Q39640199-134AB95A-6E7A-4C4F-9E0B-F43E09CB25D9Q39695256-1EB5C935-30DE-4845-8F8E-CF85D56E2D82Q40074756-0B8D1CF6-7319-44C6-B18A-DEDB7CE2A556Q41315974-F781434D-9540-4C51-BE84-319BD21FF8BAQ41427931-A2B582F9-D52B-4B83-94BD-843BE6151256
P2860
Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@ast
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@en
type
label
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@ast
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@en
prefLabel
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@ast
Moraxella (Branhamella) catarr ...... ts of a rediscovered pathogen.
@en
P1476
Moraxella (Branhamella) catarr ...... cts of a rediscovered pathogen
@en
P2093
McKenzie H
P304
P356
10.1099/00222615-46-5-360
P50
P577
1997-05-01T00:00:00Z